AMENDMENT NO. 1 TO LICENSE AGREEMENTLicense Agreement • March 16th, 2020 • AVROBIO, Inc. • Biological products, (no disgnostic substances)
This AMENDMENT NO. 1 TO LICENSE AGREEMENT (herein referred to as “Amendment No. 1”) is made and entered into as of this 21st day of February, 2018 (the “Amendment No. 1 Effective Date”), between BioMarin Pharmaceutical Inc., a Delaware corporation, with offices at 770 Lindaro Street, San Rafael, CA 94901 (“BioMarin”), and AVROBIO, Inc., a Delaware corporation having a place of business at 700 Technology Square, Suite 101, Cambridge, MA 02139 (“AVROBIO”). Each of BioMarin and “AVROBIO” may be referred to herein as a “Party” or collectively as the “Parties.”
AVROBIO, INC. EMPLOYMENT AGREEMENTEmployment Agreement • March 16th, 2020 • AVROBIO, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This Employment Agreement (“Agreement”) is made as of the 1st day of September, 2018, between AVROBIO, Inc., a Delaware corporation (the “Company”), and Deanna Petersen (the “Executive”) and is effective as of the closing of the Company’s first underwritten public offering of its equity securities pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Effective Date”).
AMENDMENT NO. 2 TO LICENSE AGREEMENTLicense Agreement • March 16th, 2020 • AVROBIO, Inc. • Biological products, (no disgnostic substances)
This AMENDMENT NO. 2 TO LICENSE AGREEMENT (herein referred to as “Amendment No. 2”) is made and entered into as of this 7th day of January, 2020 (the “Amendment No. 2 Effective Date”), between BioMarin Pharmaceutical Inc., a Delaware corporation, with offices at 770 Lindaro Street, San Rafael, CA 94901 (“BioMarin”), and AVROBIO, Inc., a Delaware corporation having a place of business at One Kendall Square, Building 300, Suite 201, Cambridge, MA 02139 (“AVROBIO”). Each of BioMarin and “AVROBIO” may be referred to herein as a “Party” or collectively as the “Parties.”
